Severe anaemia affects kidney disease patients, with haemoglobin levels dropping significantly. Early erythropoietin (EPO) treatment can improve haemoglobin and slow kidney disease progression, though access to care varies.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: